Chemours Co
CCNYSEMaterials · Chemicals & Allied Products · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.37B | $1.36B | $6.08B | $6.83B | $6.34B | $4.97B |
| Operating income | — | — | — | — | — | — |
| Net income | −$5.0M | $54.0M | −$253.0M | $578.0M | $608.0M | $219.0M |
| Total assets | $7.38B | $7.51B | $8.24B | $7.64B | $7.55B | $7.08B |
| Total liabilities | $6.81B | $6.94B | $7.52B | $6.53B | $6.47B | $6.27B |
| Equity | $566.0M | $571.0M | $721.0M | $1.11B | $1.08B | $813.0M |
| EPS (diluted) | $-0.03 | $0.36 | $-1.70 | $3.65 | $3.60 | $1.32 |
| Shares out. | 149.4M | 148.8M | 148.3M | 160.0M | 165.2M | 164.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- −0.4%
- Return on equity
- −0.9%
- Return on assets
- −0.1%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 92.3%
- Debt / equity
- 12.03×
- Book value / share
- $3.79
- Revenue growth (YoY)
- 0.4%
- Net income growth (YoY)
- −109.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- 1.5%clean
- Beneish M-Score
- -2.40normal
- Piotroski F-Score
- 3/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 2 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Revenue is growing year-over-year
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Feb 29, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Blackrock, Inc.Passive (13G)Apr 24, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Millennium Management LlcPassive (13G)Aug 8, 2025
- Fmr LlcPassive (13G)Aug 6, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Cranston Mary BDirector | May 6, 2026 | Grant | 7,182 | $0.00 |
| Turner Leslie MDirector | May 6, 2026 | Grant | 7,182 | $0.00 |
| Fletcher PamelaDirector | May 6, 2026 | Grant | 7,182 | $0.00 |
| Cowan AlisterDirector | May 6, 2026 | Grant | 7,182 | $0.00 |
| Mather CourtneyDirector | May 6, 2026 | Grant | 7,182 | $0.00 |
| Kane Erin NDirector | May 6, 2026 | Grant | 7,182 | $0.00 |
| Satterthwaite LivingstonDirector | May 6, 2026 | Grant | 7,182 | $0.00 |
| Keohane Sean DDirector | May 6, 2026 | Grant | 7,182 | $0.00 |
| Kava Joseph DanielDirector | May 6, 2026 | Grant | 7,182 | $0.00 |
| Brokaw George RDirector | May 6, 2026 | Grant | 7,182 | $0.00 |
| Wellman Kristine MOfficer — SVP, GC & Corp. Secretary | Mar 1, 2026 | Tax withholding | 3,359 | $18.24 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 9.5M | 2.5 | +12.0% |
| Apr 30, 2026 | 8.5M | 3.7 | -10.3% |
| Apr 15, 2026 | 9.5M | 3.8 | -8.5% |
| Mar 31, 2026 | 10.3M | 2.7 | -4.6% |
| Mar 13, 2026 | 10.8M | 3.2 | -14.0% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 5, 2026
- Director / officer change · Shareholder voteApr 30, 2026
- Entered a material agreement · New financial obligation · Other material eventMar 12, 2026
- Other material eventFeb 26, 2026
- Results of operationsFeb 19, 2026
- Entered a material agreement · Regulation FD disclosureJan 16, 2026
- Results of operationsNov 6, 2025
- Director / officer changeOct 31, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.